Assessing measurement invariance of MSQOL-54 across Italian and English versions
Andrea Giordano(Fondazione IRCCS Istituto Neurologico Carlo Besta), Rosalba Rosato(Tumori Foundation), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Silvia Testa(University of Aosta Valley), Ugo Nocentini(University of Rome Tor Vergata), Paolo Confalonieri(Fondazione IRCCS Istituto Neurologico Carlo Besta), Antonio Bertolotto(Neuroscience Institute), Erika Pietrolongo(University of Chieti-Pescara), Marta Bassi(University of Milan), Alysha De Livera(The University of Melbourne), Monica Falautano, Maria Esmeralda Quartuccio(Carlo Forlanini Hospital), Claudia Niccolai(Don Carlo Gnocchi Foundation), Monica Grobberio(Azienda Socio Sanitaria Territoriale Lariana), Beatrice Allegri, Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Alessandra Solari(Fondazione IRCCS Istituto Neurologico Carlo Besta), Elisa Ferriani(Azienda USL di Bologna), George A Jelinek(The University of Melbourne), Eleonora Cocco(University of Cagliari), Maria Grazia Grasso(University of Palermo), Ambra Mara Giovannetti, Rosa Gemma Viterbo(University of Bari Aldo Moro), Sabina Cilia
Cited by 13
Related Papers
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
Multiple Sclerosis Severity Score
|Neurology|2005|959
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Overexpression of the Cytokine BAFF and Autoimmunity Risk
|New England Journal of Medicine|2017|396
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309